Mendenhall William M, Holtzman Adam L, Dagan Roi, Bryant Curtis M, Hitchcock Kathryn E, Amdur Robert J, Fernandes Rui P
Department of Radiation Oncology, University of Florida College of Medicine, Gainesville and Jacksonville, FL, USA.
Department of Oral Maxillofacial Surgery, University of Florida Health, Jacksonville, FL, USA.
Craniomaxillofac Trauma Reconstr. 2021 Mar;14(1):79-83. doi: 10.1177/1943387520971418. Epub 2020 Nov 3.
Literature review.
To review the current role of radiotherapy (RT) in the management of oral cavity squamous cell carcinoma (SCC).
Review of selected literature.
T1-T2N0 SCCs may be treated with either RT alone or surgery with a high likelihood of cure. The pendulum swung toward surgery with postoperative RT (PORT) added depending on the pathological findings in the mid 1980s. Patients with positive margins, extranodal extension (ENE), and/or 4 or more positive nodes receive concomitant chemotherapy (POCRT). Patients with T3-T4 and/or positive regional nodes are treated with surgery and PORT alone or POCRT. The likelihood of cure is moderate to low depending on extent of disease. The likelihood of major complications ranges from 10% to 30% depending on the method of reconstruction and the aggressiveness of postoperative PORT/POCRT. Patients with very advanced disease are treated with palliative RT, chemotherapy, or supportive care.
The role of RT in the management of oral cavity SCC is primarily in the postoperative setting with palliative RT being reserved for those with very advanced disease where the likelihood of cure is remote.
文献综述。
回顾放射治疗(RT)在口腔鳞状细胞癌(SCC)管理中的当前作用。
对选定文献进行综述。
T1 - T2N0期SCC可单独采用RT或手术治疗,治愈可能性高。在20世纪80年代中期,根据病理结果,治疗方式转向术后加用放射治疗(PORT)的手术治疗。切缘阳性、结外扩展(ENE)和/或4个或更多阳性淋巴结的患者接受同步化疗(POCRT)。T3 - T4期和/或区域淋巴结阳性的患者单独接受手术和PORT或POCRT治疗。根据疾病范围,治愈可能性为中度至低度。主要并发症的发生率根据重建方法和术后PORT/POCRT的激进程度在10%至30%之间。疾病非常晚期的患者接受姑息性RT、化疗或支持治疗。
RT在口腔SCC管理中的作用主要在术后,姑息性RT则用于治愈可能性极小的非常晚期疾病患者。